Video Experimental Relacionado
Updated: Jul 19, 2026
08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Resumen
Más del 98% de las mutaciones de la fibrosis quística son detectables en Bretaña.
Área de la Ciencia:
- Genética médica La genética médica.
- Salud de la población Salud de la población
Sus antecedentes:
- La fibrosis quística (FQ) es un trastorno genético.
- Las mutaciones genéticas son la causa de la FC.
- Las poblaciones específicas pueden tener perfiles de mutación únicos.
Objetivo del estudio:
- Evaluar la viabilidad del cribado de portadores para la fibrosis quística.
- Para evaluar la prevalencia de las mutaciones de la fibrosis quística en Bretaña, Francia.
Principales métodos:
- Análisis genético de una población celta en Bretaña.
- Detección de mutaciones para la fibrosis quística.
Principales resultados:
- Más del 98% de las mutaciones de fibrosis quística se identificaron en la población bretona.
- La alta tasa de detección sugiere potencial para el cribado de portadores.
Conclusiones:
- El cribado de portadores para la fibrosis quística es altamente factible en Bretaña.
- Los programas de cribado genético podrían implementarse de manera efectiva en esta población.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...